Medicare Enrolled
Dr. Vijay Patel, M.D.
Pulmonary Disease · Newnan, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Patel
Dr. Vijay Patel is a pulmonary disease specialist in Newnan, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Patel performed 2,299 Medicare services across 1,786 unique beneficiaries.
Between the years covered by Open Payments, Dr. Patel received a total of $23,342 from 62 pharmaceutical and/or device companies across 861 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 13% volume in GA
$23,342 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,299
Medicare services
Top 13% in GA for pulmonary disease
1,786
Unique beneficiaries
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~115 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
863 | $83 | $370 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing patterns, and sleep duration. This test records physiological data while you sleep to assess your sleep quality and breathing function. |
258 | $28 | $156 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
232 | $11 | $54 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
103 | $39 | $189 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
100 | $37 | $184 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
99 | $26 | $203 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
94 | $121 | $496 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
93 | $8 | $23 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
83 | $24 | $117 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
77 | $103 | $561 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
55 | $86 | $457 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
44 | $87 | $474 |
| New patient office visit, complex (60-74 min) | 39 | $156 | $705 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
38 | $72 | $219 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
37 | $31 | $57 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
29 | $6 | $30 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
28 | $51 | $253 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
27 | $93 | $355 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$23,342
Total received (2018-2024)
Avg $3,335/year across 7 years
Top 10% in GA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
62
Companies
861
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,155 (99.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$187 (0.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,024
2023
$4,999
2022
$3,041
2021
$2,740
2020
$2,924
2019
$2,851
2018
$2,763
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$822
AstraZeneca Pharmaceuticals LP
$611
GENZYME CORPORATION
$551
JAZZ PHARMACEUTICALS INC.
$383
HARMONY BIOSCIENCES LLC
$249
Merck Sharp & Dohme LLC
$146
Regeneron Healthcare Solutions, Inc.
$135
Boehringer Ingelheim Pharmaceuticals, Inc.
$125
Inspire Medical Systems, Inc.
$103
United Therapeutics Corporation
$98
Harmony Biosciences Llc
$94
Amgen Inc.
$91
Electromed, Inc.
$85
Axsome Therapeutics, Inc.
$81
Baxter Healthcare
$78
Takeda Pharmaceuticals U.S.A., Inc.
$67
Bayer Healthcare Pharmaceuticals Inc.
$56
Grifols USA, LLC
$44
Mylan Specialty L.P.
$39
3B Medical, Inc.
$34
PFIZER INC.
$23
Insmed, Inc.
$22
Abbott Laboratories
$21
Pulmonx Corporation
$19
Vifor Pharma, Inc.
$18
ANI Pharmaceuticals, Inc.
$15
Tactile Systems Technology Inc
$15
Top 3 companies account for 49.3% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$3,441
AstraZeneca Pharmaceuticals LP
$2,381
Actelion Pharmaceuticals US, Inc.
$1,485
Intuitive Surgical, Inc.
$1,437
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,342
Sunovion Pharmaceuticals Inc.
$1,245
GENZYME CORPORATION
$1,197
Harmony Biosciences LLC
$987
Abbott Laboratories
$742
Medtronic, Inc.
$698
JAZZ PHARMACEUTICALS INC.
$648
Mylan Specialty L.P.
$636
United Therapeutics Corporation
$528
HARMONY BIOSCIENCES LLC
$499
Electromed, Inc.
$477
Regeneron Healthcare Solutions, Inc.
$423
Insmed, Inc.
$415
Shire North American Group Inc
$411
Grifols USA, LLC
$329
Takeda Pharmaceuticals U.S.A., Inc.
$290
Inspire Medical Systems, Inc.
$277
PFIZER INC.
$238
Respicardia, Inc.
$177
Edwards Lifesciences Corporation
$159
Baxter Healthcare
$158
Genentech USA, Inc.
$155
CVRx, Inc.
$154
Axsome Therapeutics, Inc.
$153
Merck Sharp & Dohme LLC
$146
Mallinckrodt Enterprises LLC
$145
Eisai Inc.
$140
EISAI INC.
$139
Pulmonx Corporation
$135
Amgen Inc.
$131
Bayer Healthcare Pharmaceuticals Inc.
$115
SANOFI-AVENTIS U.S. LLC
$99
Mallinckrodt Hospital Products Inc.
$95
Harmony Biosciences Llc
$94
Inogen, Inc.
$92
Jazz Pharmaceuticals Inc.
$91
Merck Sharp & Dohme Corporation
$90
ANI Pharmaceuticals, Inc.
$85
Advanced Respiratory, Inc
$65
Lilly USA, LLC
$64
Mallinckrodt LLC
$59
Teva Pharmaceuticals USA, Inc.
$52
Bayer HealthCare Pharmaceuticals Inc.
$46
CSL Behring
$46
Medtronic USA, Inc.
$45
Stryker Corporation
$40
Novartis Pharmaceuticals Corporation
$40
3B Medical, Inc.
$34
Novo Nordisk Inc
$26
Phadia US Inc.
$26
Circassia Pharmaceuticals Inc
$24
Optinose US, Inc.
$22
Vifor Pharma, Inc.
$18
Tactile Systems Technology Inc
$15
Allergan, Inc.
$14
Veran Medical Technologies, Inc.
$13
Allergan Inc.
$11
Janssen Pharmaceuticals, Inc
$6
Top 3 companies account for 31.3% of all-time payments
Associated products mentioned in payments ›
120V · 60Hz · ACTHAR · AIRSUPRA · ANDEXXA · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Adempas · AirDuo Digihaler · Arikayce · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREZTRI · BROVANA · Barostim Neo System · CHANTIX · CHARTIS CATHETER · CINRYZE · COREVALVE EVOLUT R · CUTAQUIG · CUVITRU · DALVANCE · DUAKLIR PRESSAIR · DUPIXENT · Da Vinci Surgical System · Dayvigo · Dymista · ELIQUIS · EPIC · Esbriet · FARXIGA · FASENRA · FUSION · Flexitouch Plus · GLASSIA · HYQVIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · Hizentra · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · INSPIRIS RESILIA AORTIC VALVE · ImmunoCAP · InogenOne · Inspire Upper Airway Stimulation System · JANUVIA · LONHALA MAGNAIR · LUNA · LYRICA · Life 2000 Ventilation System · NUCALA · OFEV · OPSUMIT · ORENITRAM · Ozempic · PANZYGA · POMPE - DISEASE · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Perforomist · ProAir Digihaler · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · SMARTVEST · SPIRIVA RESPIMAT · SPY-PHI SYSTEM · SPiN Thoracic Navigation System · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TEZSPIRE · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TRELEGY ELLIPTA · TRULICITY · TUDORZA PRESSAIR · TYVASO · The VisiVest Airway Clearance System · UPTRAVI · UTIBRON NEOHALER · Utibron · WAKIX · WINREVAIR · Wakix · XARELTO · XOLAIR · XYREM · XYWAV · Xembify · Xhance · Xolair · YUPELRI · Yupelri · ZERBAXA · Zemaira · remede System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for pulmonary disease in GA.
Geographic Context
Pulmonary diseases within 10 mi
9
Per 100K population
6.0
County median income
$94,142
Nearest hospital
PIEDMONT NEWNAN HOSPITAL, INC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Patel is a clinical cardiology specialist, with above-average Medicare volume (top 13% in GA), with low-engagement industry engagement in the top 10% of GA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Patel experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Patel performed 863 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $23,342 from 62 companies across 861 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other pulmonary diseases in Newnan?
Dr. Patel's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Newnan
Browse pulmonary diseases in Newnan ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in GA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in GA
Which GA pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Actelion Pharmaceuticals US, Inc. Payments to Doctors
See all physicians who received payments from Actelion Pharmaceuticals US, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology